Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plumiaz vs Diastat in Refractory Epilepsy
NCT02474407Phase 2Terminated
- Sponsor
- Acorda Therapeutics
- Start
- Jun 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diazepam nasal spray in epilepsy, seizure cluster, sponsored by Acorda Therapeutics. Started Jun 2015; status: terminated.
02
Drugs
diazepam nasal spray
03
Conditions
epilepsyseizure cluster
Beyond the preview
Go deeper on NCT02474407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474407.